Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of aging and brain-derived neurotrophic factor signaling in expression of base excision repair genes in the human brain. | Aging Cell | 2023 | 37334527 | PubTator, text mining | PubMed |
| Androgen receptor knockdown enhances prostate cancer chemosensitivity by down-regulating FEN1 through the ERK/ELK1 signalling pathway. | Cancer Med | 2023 | 37326412 | PubTator, text mining | PubMed |
| Mitochondrial control of innate immune responses. | Front Immunol | 2023 | 37325622 | PubTator, text mining | PubMed |
| Explore the dominant factor in prime editing via a view of DNA processing. | Synth Syst Biotechnol | 2023 | 37325180 | PubTator, text mining | PubMed |
| SETD8, a frequently mutated gene in cervical cancer, enhances cisplatin sensitivity by impairing DNA repair. | Cell Biosci | 2023 | 37308924 | PubTator, text mining | PubMed |
| Temozolomide Sensitizes ARID1A-Mutated Cancers to PARP Inhibitors. | Cancer Res | 2023 | 37306706 | PubTator, text mining | PubMed |
| The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways. | Int J Mol Sci | 2023 | 37298600 | PubTator, text mining | PubMed |
| The Impact of Human DNA Glycosylases on the Activity of DNA Polymerase β toward Various Base Excision Repair Intermediates. | Int J Mol Sci | 2023 | 37298543 | PubTator, text mining | PubMed |
| Targeting IGF2BP3 in Cancer. | Int J Mol Sci | 2023 | 37298373 | PubTator, text mining | PubMed |
| WDR4 gene polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study. | J Cancer | 2023 | 37283791 | PubTator, text mining | PubMed |
| Endoparasitoid lifestyle promotes endogenization and domestication of dsDNA viruses. | Elife | 2023 | 37278068 | PubTator, text mining | PubMed |
| Merging bioactivity predictions from cell morphology and chemical fingerprint models using similarity to training data. | J Cheminform | 2023 | 37268960 | PubTator, text mining | PubMed |
| Post-translational Modifications by Acyl Groups Regulate FEN1's Activities and Play Essential Roles in Cell Proliferation and DNA Repair. | Protein Pept Lett | 2023 | 37254539 | PubTator, text mining | PubMed |
| DNA damage repair proteins across the Tree of Life. | iScience | 2023 | 37250769 | PubTator, text mining | PubMed |
| Effect of Glue Spread on Bonding Strength, Delamination, and Wood Failure of Jabon Wood-Based Cross-Laminated Timber Using Cold-Setting Melamine-Based Adhesive. | Polymers (Basel) | 2023 | 37242924 | PubTator, text mining | PubMed |
| Target-activated T7 transcription circuit-mediated multiple cycling signal amplification for monitoring of flap endonuclease 1 activity in cancer cells. | Analyst | 2023 | 37232199 | PubTator, text mining | PubMed |
| The FBXO32/ATR/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37227155 | PubTator, text mining | PubMed |
| Construction of dual exponential amplification accompanied by multi-terminal signal output method for convenient detection of tumor biomarker FEN1 activity. | Anal Chim Acta | 2023 | 37225333 | PubTator, text mining | PubMed |
| The role of mitochondria in the resistance of melanoma to PD-1 inhibitors. | J Transl Med | 2023 | 37221594 | PubTator, text mining | PubMed |
| A DNA Nano Firework for Imaging and Inhibitor Screening of Flap Endonuclease 1 in Living Cells. | Anal Chem | 2023 | 37218062 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers?page=22